# AlphaCentric Life Sciences and Healthcare Fund

AlphaCentric Life Sciences and Healthcare Fund is a registered fund series of MUTUAL FUND SERIES TRUST (series S000067055). Net assets $39.3M as of 2026-03-31.

## Profile

- Series ID: S000067055
- Registrant: MUTUAL FUND SERIES TRUST
- LEI: 549300XV4TMPQ6UX8179
- Net assets: $39.3M
- Total assets: $39.4M
- As of: 2026-03-31

## Advisers

- [Kennedy Capital Management LLC. (Subadvisor)](https://search.stillhousedata.com/firm/105834)
- [AlphaCentric Advisors LLC (Advisor)](https://search.stillhousedata.com/firm/170679)

## Top holdings (63 reported)

_Showing 15 of 63 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| [First American Funds Inc.](https://search.stillhousedata.com/security/31846V328) | — | $3.0M | 771.90% |
| [Gilead Sciences Inc.](https://search.stillhousedata.com/security/375558103) | — | $2.8M | 718.07% |
| [AstraZeneca PLC](https://search.stillhousedata.com/security/G0593M107) | — | $2.2M | 563.34% |
| [Vertex Pharmaceuticals Incorporated](https://search.stillhousedata.com/security/92532F100) | — | $2.2M | 559.96% |
| [Ionis Pharmaceuticals, Inc.](https://search.stillhousedata.com/security/462222100) | — | $1.5M | 374.03% |
| [Insmed Inc](https://search.stillhousedata.com/security/457669307) | — | $1.4M | 356.92% |
| [Incyte Corporation.](https://search.stillhousedata.com/security/45337C102) | — | $1.3M | 340.96% |
| [Roivant Sciences Ltd](https://search.stillhousedata.com/security/G76279101) | — | $1.3M | 335.78% |
| [Argenx SE](https://search.stillhousedata.com/security/04016X101) | — | $1.3M | 333.16% |
| [Neurocrine Biosciences Inc](https://search.stillhousedata.com/security/64125C109) | — | $1.3M | 321.86% |
| [Axsome Therapeutics Inc.](https://search.stillhousedata.com/security/05464T104) | — | $1.1M | 276.73% |
| [Ascendis Pharma A/S](https://search.stillhousedata.com/security/04351P101) | — | $1.0M | 263.27% |
| [Apogee Therapeutics Inc.](https://search.stillhousedata.com/security/03770N101) | — | $957K | 243.36% |
| [Protagonist Therapeutics Inc](https://search.stillhousedata.com/security/74366E102) | — | $953K | 242.31% |
| [Amgen Inc.](https://search.stillhousedata.com/security/031162100) | — | $819K | 208.40% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-03-31 | $39.3M |
| 2025-12-31 | $37.0M |
| 2025-09-30 | $34.9M |
| 2025-06-30 | $34.4M |
| 2025-03-31 | $44.2M |
| 2024-12-31 | $52.7M |
| 2024-09-30 | $82.9M |
| 2024-06-30 | $82.8M |

## More

- [Registrant: MUTUAL FUND SERIES TRUST](https://search.stillhousedata.com/registrant/1355064)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000067055.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.